Globe Newswire
BOSTON, Massachusetts, Aug. 28, 2026 (GLOBE NEWSWIRE) -- Netcapital Inc. (Nasdaq: NCPL) (the “Company”) today announced that on August 24, 2026 it received a delinquency notification letter (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, because the Company has not yet filed its Annual Report on Form 10-K for the fiscal year ended April 30, 2026 (the “Form 10-K”), the Company is not in... (continue reading...)
Expands Multifamily Presence in South Florida with Value-Add Investment
SAN DIEGO, Aug. 28, 2026 (GLOBE NEWSWIRE) -- Fairfield announced the acquisition of Portofino Place Apartments, a residential community located at 4400 Portofino Way in West Palm Beach, Florida.
Portofino Place is a multifamily community offering spacious one-, two-, and three-bedroom apartment homes, as well as two-story loft residences. Located minutes from Downtown West Palm Beach, the... (continue reading...)
BioXcel Therapeutics intends to complete a court-supervised sale transaction, in an effort to maximize value for all stakeholders
Teva Pharmaceuticals to serve as “stalking horse” bidder in a court-supervised 363 auction process
BioXcel Therapeutics has secured a commitment for debtor-in-possession (DIP) financing to support ongoing operations
NEW HAVEN, Conn., Aug. 28, 2026 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI) (“BioXcel Therapeutics” or... (continue reading...)
ASHBURN, Va., Aug. 28, 2026 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a late clinical-stage specialty pharmaceutical company focused on rare and orphan diseases, today announced that it has entered into a securities purchase agreement with new and existing healthcare-focused institutional investors to raise up to approximately $50.0 million in gross proceeds, including initial upfront funding of approximately $30.8... (continue reading...)
- Interim Analysis of the First Six Patients to Complete 12 Weeks of Treatment Met Pre-Specified Alpha Adjusted Target for Primary Endpoint with Statistical Significance
- Four of Six (66.7%) Participants Achieved the Target 1-Grade or Greater Improvement in Investigator Global Assessment at Week 12 (p=0.0087) With Statistical Significance versus the Pre-Specified Alpha of 0.0215
- Key Secondary Endpoint of Global Impression of Change Also Achieved Statistical Significance at... (continue reading...)
More Globe Newswire
View Older Stories-
Jiayin Group Inc. Reports Second Quarter 2026 Unaudited Financial Results
-
MEXC Ventures Supports Alpha Arena Bali Final as Live DEMO Competition Crowns Its Champion
-
NVRO Metals Advances Commercial Deployment of the NVRO Process™ Through Successful Continuous Production Demonstration on Hecla Greens Creek Material
-
Towngas and the International Gas Union to host major global energy event in Hong Kong this October
-
Immuron Reports FY26 Preliminary Results
-
Issue of Equity and Total Voting Rights
-
WISDOMTREE MULTI ASSET ISSUER PUBLIC LIMITED COMPANY (the “ISSUER”) (a public company incorporated with limited liability in Ireland) NOTICE IN RESPECT OF A DAILY SWAP RATE AMENDEMENT IN RESPEC
-
ZMO Launches Innovative Crypto & Stock Trading Platform Powered by 1-Click Trading™
-
Form-8.3 APTITUDE SOFTWARE GROUP PLC - 27 08 2026 - (CGAML)
-
ZMO Launches Innovative Crypto & Stock Trading Platform Powered by 1-Click Trading™
-
Form-8.3 GOOCH & HOUSEGO PLC - 27 08 2026 - (CGWL)
-
Form-8.3 ADVANCED MEDICAL SOLUTIONS GROUP PLC - 27 08 2026 - (CGWL)
-
2026 Nanjing Week Event Held in Kyrgyzstan
-
Documentary Screening & Forum Discussion - Hope for the Future: Bernard Loeffke Held in New York
-
Documentary Screening & Forum Discussion - Hope for the Future: Bernard Loeffke Held in New York
-
Cytokinetics Announces Positive Results from ACACIA-HCM Presented in Hot Line Session at the European Society of Cardiology (ESC) Congress 2026 and Published in The New England Journal of Medicine
-
2026 CIFTIS Service Trade Development Forum Series to Feature 15 Thematic Forums
-
Man Group PLC : Form 8.3 - Rotork plc
-
Transaction in Own Shares
-
Renk Group AG: Release according to Article 40 (1) of the WpHG (the German Securities Trading Act) with the objective of Europe-wide distribution
-
Share Purchase - Long Term Incentive Plans
-
CDT Validates Enhanced Solid-Form Properties Within Its IP Portfolio
-
Refinancing of Swedish floating rate loans - Nykredit Realkredit A/S
-
DIGITALIST GROUP’S HALF-YEAR REVIEW, 1 JANUARY–30 JUNE 2026
-
Form 8.5 (EPT/RI) - Pharos Energy Plc
-
BUYBACK OF RIKSBANK CERTIFICATES
-
Form 8.5 (EPT/RI) - Kore Potash Plc
-
Form 8.5 (EPT/RI) - CAB Payments Holdings Plc
-
Form 8.5 (EPT/RI) - Alternative Income REIT plc
-
Tokio Marine HCC International Acquires Direct Commercial Limited, a Leading UK Commercial Motor MGA
-
SSCP Lager Bidco AB (publ) – Interim report for second quarter 2026
-
SalMar - Share buyback program has been completed
-
Renk Group AG: Release according to Article 40 (1) of the WpHG (the German Securities Trading Act) with the objective of Europe-wide distribution
-
European Energy A/S: Interim Report H1 2026
-
GCL Announces $10 Million Share Repurchase Program
-
Dimensional Fund Advisors Ltd. : Form 8.3 - SPIRE HEALTHCARE GROUP PLC - Ordinary Shares
-
TRESU Investment Holding A/S – Announcement of Q2 2026 Interim Report
-
Dimensional Fund Advisors Ltd. : Form 8.3 - ROTORK PLC - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - PROLOGIS INC - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - MITIE GROUP PLC - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - DNO ASA - Ordinary Shares
-
STARCARES Completes Basketball Court Revamp in the Philippines, Benefiting Nearly 20,000 People
-
LUX Announces First Anniversary Under Creative Capital Ownership With Exclusive Gianan Wine Collaboration
-
Serstech receives 2.5 MSEK order from partner Allianz Technics
-
TDC NET Holding Financial Report First Half 2026
-
Annual Showcase of the 5th Cross-Language Recitation Event of Confucian Classics Held
-
Chiesi Global Rare Diseases Demonstrates Its Ongoing Commitment to the Rare Disease Community at the Society of Inborn Errors of Metabolism (SSIEM) 2026 Annual Symposium
-
Roche’s Vabysmo demonstrates sustained two-year results in a difficult-to-treat form of neovascular age-related macular degeneration (nAMD)
-
Experience Mid-Autumn Festival Like a Local in Hong Kong This September
-
Late Breaking Data from Independent Government-Funded Trial at ESC Shows Heartflow FFRCT Analysis Reduces Unnecessary Invasive Heart Procedures by Nearly Half

